000 01366 a2200373 4500
005 20250518034322.0
264 0 _c20200218
008 202002s 0 0 eng d
022 _a1873-2399
024 7 _a10.1016/j.exphem.2019.04.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCouch, Tyler
245 0 0 _aHuman erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation.
_h[electronic resource]
260 _bExperimental hematology
_c06 2019
300 _a19-24.e4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aCRISPR-Cas Systems
650 0 4 _aCell Culture Techniques
_xeconomics
650 0 4 _aCell Differentiation
650 0 4 _aCell Line, Transformed
650 0 4 _aErythroblasts
_xenzymology
650 0 4 _aGene Editing
650 0 4 _aHumans
650 0 4 _aK562 Cells
650 0 4 _aMutation
650 0 4 _aProto-Oncogene Proteins c-kit
_xgenetics
700 1 _aMurphy, Zachary
700 1 _aGetman, Michael
700 1 _aKurita, Ryo
700 1 _aNakamura, Yukio
700 1 _aSteiner, Laurie A
773 0 _tExperimental hematology
_gvol. 74
_gp. 19-24.e4
856 4 0 _uhttps://doi.org/10.1016/j.exphem.2019.04.001
_zAvailable from publisher's website
999 _c29607922
_d29607922